Home Applications 021428 Application 021428
Type NDA
Sponsor TAKEDA PHARMS USA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 PREVACID LANSOPRAZOLE TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 15MG Yes No 002 PREVACID LANSOPRAZOLE TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 30MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021428-001 PREVACID LANSOPRAZOLE 15MG TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL AB RLD 2002-08-30 N021428-002 PREVACID LANSOPRAZOLE 30MG TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL AB RLD, RS 2002-08-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 88 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N021428-001 PREVACID 15MG TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL AB RLD 2002-08-30 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N021428-002 PREVACID 30MG TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL AB RLD, RS 2002-08-30 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N021428-001 PREVACID 15MG TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL AB RLD 2002-08-30 e64feba35796…2022-09-29 23:25 UTC 2022-09 N021428-002 PREVACID 30MG TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL AB RLD, RS 2002-08-30 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N021428-001 PREVACID 15MG TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL AB RLD 2002-08-30 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N021428-002 PREVACID 30MG TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL AB RLD, RS 2002-08-30 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N021428-001 PREVACID 15MG TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL AB RLD 2002-08-30 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N021428-002 PREVACID 30MG TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL AB RLD, RS 2002-08-30 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 88 observed states.
Observed Orange Book patent history# Patent history page 1 of 2 · 64 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021428-001 6328994 2019-05-17 2002-10-28 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-001 7431942 2019-05-17 Drug product 2009-01-22 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-001 7875292 2019-05-17 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-001 9901546 2019-05-17 Drug product 2018-04-26 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-001 6328994*PED 2019-11-17 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-001 7431942*PED 2019-11-17 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-001 7875292*PED 2019-11-17 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-001 9901546*PED 2019-11-17 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-002 6328994 2019-05-17 2002-10-28 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-002 7431942 2019-05-17 Drug product 2009-01-22 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-002 7875292 2019-05-17 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-002 9901546 2019-05-17 Drug product 2018-04-26 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-002 6328994*PED 2019-11-17 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-002 7431942*PED 2019-11-17 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-002 7875292*PED 2019-11-17 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021428-002 9901546*PED 2019-11-17 Pediatric extension 74a2ff9319b5…2019-12-14 00:12 UTC 2019-12 N021428-001 6328994 2019-05-17 2002-10-28 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-001 7431942 2019-05-17 Drug product 2009-01-22 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-001 7875292 2019-05-17 Drug product 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-001 9901546 2019-05-17 Drug product 2018-04-26 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-001 6328994*PED 2019-11-17 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-001 7431942*PED 2019-11-17 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-001 7875292*PED 2019-11-17 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-001 9901546*PED 2019-11-17 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-002 6328994 2019-05-17 2002-10-28 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-002 7431942 2019-05-17 Drug product 2009-01-22 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-002 7875292 2019-05-17 Drug product 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-002 9901546 2019-05-17 Drug product 2018-04-26 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-002 6328994*PED 2019-11-17 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-002 7431942*PED 2019-11-17 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-002 7875292*PED 2019-11-17 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021428-002 9901546*PED 2019-11-17 Pediatric extension 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021428-001 6328994 2019-05-17 2002-10-28 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021428-001 7431942 2019-05-17 Drug product 2009-01-22 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021428-001 7875292 2019-05-17 Drug product b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021428-001 9901546 2019-05-17 Drug product 2018-04-26 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021428-001 6328994*PED 2019-11-17 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021428-001 7431942*PED 2019-11-17 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021428-001 7875292*PED 2019-11-17 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021428-001 9901546*PED 2019-11-17 Pediatric extension b00525d2431f…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 18 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 21695-106 Prevacid SoluTab lansoprazole Rebel Distributors Corp NDA Current 55154-0253 Prevacid lansoprazole Cardinal Health NDA Current 55154-0253 Prevacid lansoprazole Cardinal Health 107, LLC NDA Current 55154-0253 Prevacid lansoprazole Cardinal Health NDA Current 64764-543 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current 64764-543 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current 64764-543 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current 64764-543 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current 64764-543 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current 64764-543 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current 64764-543 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current 64764-544 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current 64764-544 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current 64764-544 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current 64764-544 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current 64764-544 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current 64764-544 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current 64764-544 Prevacid SoluTab lansoprazole Takeda Pharmaceuticals America, Inc. NDA Current